-
Morning Alert: Cytokinetics, Incorporated (NASDAQ:CYTK), Keryx Biopharmaceuticals Inc. (NASDAQ:KERX), HEICO Corporation (NYSE:HEI), Hudson Global, Inc (NASDAQ:HSON), White Mountains Insurance Group, (NYSE:WTM)
On Monday shares of Cytokinetics, Incorporated (NASDAQ:CYTK) closed at $6.65. Company’s sales growth for last 5 years was -10.50% and EPS growth for next 5 years is recorded as 15.00%. Zacks downgraded shares of Cytokinetics, Inc. (NASDAQ:CYTK) from a buy rating to a hold rating. Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) in last trading activity increased 14.81%…
-
Active Watch List: Receptos (NASDAQ:RCPT), Cytokinetics, Incorporated (NASDAQ:CYTK), EMC Corporation (NYSE:EMC), Oncothyreon Inc (NASDAQ:ONTY), Albany Molecular Research Inc. (NASDAQ:AMRI)
On Friday shares of Receptos, Inc. (NASDAQ:RCPT) closed at $153.86. On May 7, Receptos, Inc. (NASDAQ:RCPT), announced that Faheem Hasnain, its President and Chief Executive Officer, will be presenting at the Bank of America Merrill Lynch 2015 Healthcare Conference at the Encore Hotel in Las Vegas, NV. The presentation is scheduled for Wednesday, May 13th…
-
Why Need to Watch: Cytokinetics, Incorporated (NASDAQ:CYTK), Benefitfocus (NASDAQ:BNFT), Merchants Bancshares Inc. (NASDAQ:MBVT), Anworth Mortgage Asset (NYSE:ANH), Canadian Pacific Railway (NYSE:CP)
On Thursday shares of Cytokinetics, Incorporated (NASDAQ:CYTK) closed at $5.99. Company’s sales growth for last 5 years was -10.50% and EPS growth for next 5 years is recorded as 15.00%. On April 30, Cytokinetics, Incorporated (NASDAQ:CYTK) reported total research and development revenues for the first quarter of 2015 were $4.4 million, compared to $8.0 million…
-
Momentum Stocks: Celgene Corporation (NASDAQ:CELG), Cytokinetics, Incorporated (NASDAQ:CYTK), General Motors Company (NYSE:GM), Telephone & Data Systems Inc. (NYSE:TDS), Media General (NYSE:MEG)
On Friday shares of Celgene Corporation (NASDAQ:CELG) closed at $110.55. Company’s sales growth for last 5 years was 23.30% and EPS growth for next 5 years is recorded as 25.46%. Celgene Corp (NASDAQ:CELG) reported net product sales of $2,055 million for the first quarter of 2015. Net product sales grew 20 percent from the same…
-
Today’s Hot List: Keryx Biopharmaceuticals Inc. (NASDAQ:KERX), Cytokinetics, Incorporated (NASDAQ:CYTK), Marlin Midstream Partners (NASDAQ:FISH), Samson Oil & Gas (NYSEMKT:SSN), Tenet Healthcare (NYSE:THC)
On Thursday shares of Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) closed at $10.66. Company’s sales growth for last 5 years was -15.60%. Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) announced the completion of the previously announced transition of the CEO role from Ron Bentsur to Greg Madison. Cytokinetics, Incorporated (NASDAQ:CYTK) in last trading activity moved down -6.12% to close at…
-
News Buzz: John B Sanfilippo & Son Inc. (NASDAQ:JBSS), Cytokinetics, Incorporated (NASDAQ:CYTK), Hilltop Holdings Inc. (NYSE:HTH), ORBCOMM (NASDAQ:ORBC), MidWest One Financial (NASDAQ:MOFG)
On Tuesday shares of John B Sanfilippo & Son Inc. (NASDAQ:JBSS) closed at $51.51. Company’s sales growth for last 5 years was 7.10%. -John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS) announced operating results for its fiscal 2015 third quarter. Net income for the first three quarters of fiscal 2015 was $20.8 million, or $1.86 per…
-
Why Need to Watch: Itau Unibanco Holding SA (ADR) (NYSE:ITUB), Cytokinetics, Incorporated (NASDAQ:CYTK), Mast Therapeutics (NYSEMKT:MSTX), Heidrick & Struggles International (NASDAQ:HSII)
On Monday shares of Itau Unibanco Holding SA (ADR) (NYSE:ITUB) closed at $13.08. Company’s sales growth for last 5 years was 10.60% and EPS growth for next 5 years is recorded as 12.10%. Stock analysts at JPMorgan Chase & Co. cut their target price on shares of Itau Unibanco Holding SA (NASDAQ:ITUB) from $14.00 to…
-
Hot Watch List: Celgene Corporation (NASDAQ:CELG), Cytokinetics, Incorporated (NASDAQ:CYTK), Workday (NYSE:WDAY), PNM Resources (NYSE:PNM), Bovie Medical Corporation (NYSEMKT:BVX)
On Friday shares of Celgene Corporation (NASDAQ:CELG) closed at $118.71. Company’s sales growth for last 5 years was 23.30% and EPS growth for next 5 years is recorded as 25.46%. Celgene Corp.( NASDAQ:CELG) announced that it has fulfilled the accelerated approval requirements for Pomalyst (pomalidomide) based on results from MM-003, an international phase III study…
-
Top Stories: Cytokinetics, Incorporated (NASDAQ:CYTK), Neurocrine Biosciences Inc. (NASDAQ:NBIX), KMG Chemicals Inc. (NYSE:KMG), Capstead Mortgage Corp. (NYSE:CMO), Crown Media Holdings Inc. (NASDAQ:CRWN)
On Monday shares of Cytokinetics, Incorporated (NASDAQ:CYTK) closed at $7.12. Company’s sales growth for last 5 years was -10.50% and EPS growth for next 5 years is recorded as 15.00%. Cytokinetics, Incorporated (NASDAQ:CYTK) sports a Zacks Rank #1 (Strong Buy). Neurocrine Biosciences Inc. (NASDAQ:NBIX) has 1.00% insider ownership while its institutional ownership stands at 91.80%.…
-
Trader’s Watch List: Cytokinetics, Incorporated (NASDAQ:CYTK), Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH), SunEdison (NYSE:SUNE), General Motors Company (NYSE:GM), RCS Capital Corporation (NYSE:RCAP)